USPTO serial 79279353
DEVATIS
Reviewed by CopyMark Law Group
Reg. 6197643Status 706Renewal
- Filing date
- Status date
- Registration date
- Nov 17, 2020
- Examiner
- FALK, JONATHAN ROBERT
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DEVATIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicholas D. Wells
Nicholas D. Wells Legends Law Group, PLLC330 MAIN ST.KAYSVILLE, UT 84037United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in treating by inhibiting the growth of tumors, as antiparasitics, and for treatment of the nervous systems, orthopedic and musculoskeletal disease, respiratory disease, genital and urologic disease, endocrinology disease, cardiovascular disease, dermatological disease, metabolic disease, gastrointestinal disease, hormonal diseases, ophthalmological disease, cancer and diseases of the blood, and for use in treating immune function, psychiatric disorders, fatigue, and sexual disfunction; veterinary preparations for use in treating by inhibiting the growth of tumors, as antiparasitics, and for treatment of the nervous systems, orthopedic and musculoskeletal disease, respiratory disease, genital and urologic disease, endocrinology disease, cardiovascular disease, dermatological disease, metabolic disease, gastrointestinal disease, hormonal diseases, ophthalmological disease, cancer and diseases of the blood, and for use in treating immune function, psychiatric disorders, fatigue, and sexual disfunction; sanitary preparations for medical purposes; dietetic foods namely, food supplements and dietary supplements adapted for medical use; dietetic sugar for medical use; food for babies; dietary supplements for humans and animals; medical plasters, materials for dressings; material for stopping teeth, dental wax; all purpose disinfectants; preparations for destroying vermin; fungicides, herbicides | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DEVA HOLDING ANONIM SIRKETI
- Other trademarks owned by DEVA HOLDING ANONIM SIRKETI
- Other trademarks owned by DEVA HOLDING ANONIM SIRKETI
- Other trademarks in Class 005
- Similar marks named DEVATIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 13, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Aug 10, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 11, 2026 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 17, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 6, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 18, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 20, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 20, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 17, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 4, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 3, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 29, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 25, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |